Mark Swingle, Ph.D.

2006 University of South Alabama, Mobile, AL, United States 
"Mark Swingle"
Mean distance: (not calculated yet)


Sign in to add mentor
Richard Honkanen grad student 2006 University of South Alabama
 (Structure of protein phosphatase 5.)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Shuhaibar LC, Kaci N, Egbert JR, et al. (2021) Phosphatase inhibition by LB-100 enhances BMN-111 stimulation of bone growth. Jci Insight. 6
Papke CM, Smolen KA, Swingle MR, et al. (2021) A disorder-related variant (E420K) of a PP2A-regulatory subunit (PPP2R5D) causes constitutively active AKT-mTOR signaling and uncoordinated cell growth. The Journal of Biological Chemistry. 100313
D'Arcy BM, Swingle MR, Schambeau L, et al. (2019) Development of a Synthetic 3-ketosteroid Δ-dehydrogenase for the Generation of a Novel Catabolic Pathway Enabling Cholesterol Degradation in Human Cells. Scientific Reports. 9: 5969
D'Arcy BM, Swingle MR, Papke CM, et al. (2019) The Antitumor Drug LB-100 is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Catalytic Metals in the Active Site of PP5C. Molecular Cancer Therapeutics
Swingle MR, Honkanen RE. (2018) Inhibitors of Serine/Threonine Protein Phosphatases: Biochemical and Structural Studies Provide Insight for Further Development. Current Medicinal Chemistry
Choy MS, Swingle M, D'Arcy B, et al. (2017) The PP1:tautomycetin complex reveals a path towards the development of PP1-specific inhibitors. Journal of the American Chemical Society
Swingle M, Volmar CH, Saldanha SA, et al. (2016) An Ultra-High-Throughput Screen for Catalytic Inhibitors of Serine/Threonine Protein Phosphatases Types 1 and 5 (PP1C and PP5C). Journal of Biomolecular Screening
Chattopadhyay D, Swingle MR, Salter EA, et al. (2016) Crystal Structures and Mutagenesis of PPP-family ser/thr Protein Phosphatases Elucidate the Selectivity of Cantharidin and Novel Norcantharidin-based Inhibitors of PP5C. Biochemical Pharmacology
Swingle MR, Honkanen RE. (2014) Development and validation of a robust and sensitive assay for the discovery of selective inhibitors for serine/threonine protein phosphatases PP1α (PPP1C) and PP5 (PPP5C). Assay and Drug Development Technologies. 12: 481-96
Yang X, Liu Y, Yang XM, et al. (2011) Cardioprotection by mild hypothermia during ischemia involves preservation of ERK activity. Basic Research in Cardiology. 106: 421-30
See more...